Last updated: October 30, 2019
Sponsor: Lake Washington Vascular
Overall Status: Active - Recruiting
Phase
N/A
Condition
Vascular Diseases
Varicose Veins
Occlusions
Treatment
N/AClinical Study ID
NCT04146168
2019-02
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age ≥18 years; 2. Treatment of the great, small or accessory saphenous vein or anycombination of saphenous veins with the Venaseal Closure System; 3. Treatment occurred atleast 30 months prior to study; 4. Ability to understand the requirements of the study andto provide informed consent.
Exclusion
Exclusion Criteria:
- Subsequent treatment (such as laser or radiofrequency ablation) of venous disease intargeted vein segment after Venaseal closure; 2. Patients in whom index procedureinformation is unavailable; 3. Patients unwilling to undergo ultrasound evaluation andclinical examination of the previously treated limb; 4. Limbs that were treated in theVeClose trial (patients who participated in VeClose and later had contralateral limbtreatment will be included).
Study Design
Total Participants: 124
Study Start date:
November 01, 2019
Estimated Completion Date:
March 31, 2020
Study Description
Connect with a study center
Lake Washington Vascular
Bellevue, Washington 98004
United StatesActive - Recruiting
Lake Washington Vascular
Issaquah, Washington 98027
United StatesActive - Recruiting
Lake Washington Vascular
Kirkland, Washington 98034
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.